Representing the developed world, the United States will maintain a 6.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$306.6 Million to the region's size and clout in the next 5 to 6 years. Over US$260.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Consumables/Reagents will reach a market size of US$658.3 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.1% over the next couple of years and add approximately US$2.5 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include, among others,
- Agilent Technologies Inc.
- Aurora Biomed Inc.
- Axxam SpA
- BD Biosciences
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- BioTek Instruments Inc.
- BMG LABTECH GmbH
- Charles River Laboratories International Inc.
- Corning Inc.
- Danaher Corporation
- DiscoveRx Corporation
- Evotec AG
- F. Hoffmann-La Roche Ltd.
- Genedata AG
- IntelliCyt® Corporation
- Luminex Corporation
- Molecular Devices Inc.
- Pall ForteBio LLC
- PerkinElmer Inc.
- Sigma-Aldrich Corp.
- Tecan Group Ltd.
- Thermo Fisher Scientific Inc.
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
High Throughput Screening (HTS): A Prelude
Recent Market Activity
HTS: The Mainstream Technology for Drug Discovery Programs
Unparalleled Advantages in Compound Screening Drives Wider Adoption
Key Benefits of HTS - An Overview
Soaring R&D Spending Creates Conducive Environment for HTS
Shift towards High Throughput Research Builds Momentum for HTS
Upward Trajectory in Med Tech Sector Generates Parallel Opportunities
Stable Economic Outlook to Keep Market Sentiment Intact in the Near Term
Developed Regions: Key Revenue Contributors
HTS Adoption Continues to Expand in Developing Regions
Key Factors Driving Demand for HTS in the Developing Regions
Leading Players in the World HTS Market
Global Competitor Market Shares
High Throughput Screening (HTS) Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
2. FOCUS ON SELECT PLAYERS
Agilent Technologies, Inc. (USA)
Aurora Biomed, Inc. (Canada)
Axxam SpA (Italy)
BD Biosciences (USA)
Danaher Corporation (USA)
Beckman Coulter, Inc. (USA)
Molecular Devices Inc. (USA)
Pall ForteBio LLC (USA)
Bio-Rad Laboratories, Inc. (USA)
BioTek Instruments Inc. (USA)
BMG LABTECH GmbH (Germany)
Charles River Laboratories International, Inc. (USA)
Corning Inc. (USA)
DiscoveRx Corporation (USA)
Evotec AG (Germany)
F. Hoffmann-La Roche Ltd. (Switzerland)
Genedata AG (Switzerland)
IntelliCyt® Corporation (USA)
Luminex Corporation (USA)
PerkinElmer, Inc. (USA)
Sigma-Aldrich Corp. (USA)
Tecan Group Ltd. (Switzerland)
Thermo Fisher Scientific Inc. (USA)
3. MARKET TRENDS & DRIVERS
Cell-based Assay: The Widely Used HTS Technology
Resolving Technical Limitations: Cornerstone for Future Success of Cell-based HTS
HTS Aims to Expand Use Case in Biochemical Applications
Label-Free HTS Demonstrates Fastest Growth
Lab-on-a-Chip HTS Seeks to Proliferate the Market
Bioinformatics HTS Enhanced with Computational Algorithms
Positive Prognosis across End-Use Markets to Underpin Revenue Growth
Pharmaceutical Industry Leads the Way
HTS Deployments Soar in Academia
Progressive Advancements in HTS Instruments Accelerate Market Growth
Microplate Handling Systems: An Important HTS Instrument Type
Liquid Handling Devices: A Necessity in HTS Processes
Microscopic Systems Facilitate Seamless Quantitative Analysis
Advanced Software Platforms Augment HTS Proficiency
Services: An Important Revenue Generating Segment
Expansion in Compound Libraries Widens Functional Scope of HTS
Compound Libraries Facilitate Simultaneous Functional Genomics & Small Molecule Analysis
Laboratory Automation & Miniaturization Spell Opportunities for HTS
Miniaturization of Compound Screening Processes Drives Demand for HTS
HTS Miniaturization - Technology Developments
HTS Robotics Support Miniaturization
IVC - A Miniaturized, Powerful HTS Technology
HTS Assumes Critical Importance in Target Identification & Validation
HTS Gathers Steam in Primary Screening Applications
HTS Perceives Bright Future in Stem Cell Research
HTS in Kinase Inhibitors Identification
HTS in Alzheimer's Disease Drug Discovery
HTS for Less Simplified PCR Systems
HTFC Eases Metabolic Activity Analysis for Pharmaceutical Drugs
Open Access Platforms Widen HTS Audience Base
Need for Stringent QA System to Keep Failures at Bay
High Throughput Screening (HTS) Vs. High Content Screening (HCS)
Rise in Adoption of HCS Technology in HTS Laboratories
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
Market Facts & Figures
US High Throughput Screening (HTS) Market Share (in %) by Company: 2020 & 2025
Market Facts & Figures
European High Throughput Screening (HTS) Market: Competitor Market Share Scenario (in %) for 2020 & 2025
REST OF EUROPE
REST OF ASIA-PACIFIC
REST OF LATIN AMERICA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
Total Companies Profiled: 104